Siddhartha Yadav, Associate Professor of Oncology and Consultant Medical Oncologist at the Mayo Clinic, shared a post on LinkedIn:
“Excited to see two of our studies published this month in Gynecologic Oncology.
One examines prehabilitation during neoadjuvant chemotherapy for advanced ovarian cancer, showing that participation in a prehabilitation program was associated with improved surgical candidacy and better chemotherapy outcomes.
The other evaluates transcriptome profiling in endometrial cancer, highlighting its potential to improve prognostic assessment, identify platinum-insensitive disease, and inform precision treatment strategies.”
Title: Prehabilitation during neoadjuvant chemotherapy in advanced ovarian cancer is associated with improved surgical candidacy and chemotherapy outcomes
Authors: Riham Suleiman, Shilpa Mokshagundam, Matthew S. Block, Andrea E. Wahner Hendrickson, Kelly H. Bruce, William A. Cliby, Carrie L. Langstraat, S. John Weroha, Siddhartha Yadav, Amanika Kumar
Title: Clinical relevance of transcriptome profiling for assessing prognosis, platinum insensitivity, and precision therapeutics in endometrial cancer
Authors: Jesus Gonzalez-Bosquet, Maryam Shahi, Siddhartha Yadav, Nisha Kanwar, Amanda L. Tapia, Michaela E. McGree, Sean C. Dowdy, Fergus J. Couch, Kevin C. Halling, S. John Weroha, Jamie N. Bakkum-Gamez, Karl C. Podratz
Other articles featuring Siddhartha Yadav on OncoDaily.